Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents.

Mabeta P, Pepper MS.

Angiogenesis. 2009;12(1):81-90. doi: 10.1007/s10456-009-9134-8.

PMID:
19214765
2.

ENMD-1198, a new analogue of 2-methoxyestradiol, displays both antiangiogenic and vascular-disrupting properties.

Pasquier E, Sinnappan S, Munoz MA, Kavallaris M.

Mol Cancer Ther. 2010 May;9(5):1408-18. doi: 10.1158/1535-7163.MCT-09-0894.

3.

[Novobiocin inhibits angiogenesis and shows synergistic effect with vincristine].

Yang J, Jiang M, Zhen YS.

Yao Xue Xue Bao. 2003 Oct;38(10):731-4. Chinese.

PMID:
14730893
4.

Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells.

Kalishwaralal K, Banumathi E, Ram Kumar Pandian S, Deepak V, Muniyandi J, Eom SH, Gurunathan S.

Colloids Surf B Biointerfaces. 2009 Oct 1;73(1):51-7. doi: 10.1016/j.colsurfb.2009.04.025.

PMID:
19481908
6.

Anti-angiogenic activity of heparin-like polysulfonated polymeric drugs in 3D human cell culture.

García-Fernández L, Halstenberg S, Unger RE, Aguilar MR, Kirkpatrick CJ, San Román J.

Biomaterials. 2010 Nov;31(31):7863-72. doi: 10.1016/j.biomaterials.2010.07.022.

PMID:
20674006
7.

Opposite effects of endostatin on different endothelial cells.

Schmidt A, Addicks K, Bloch W.

Cancer Biol Ther. 2004 Nov;3(11):1162-6; discussion 1167-8.

PMID:
15640622
8.

[In vitro inhibitory effect of 23-HBA on angiogenesis].

Jiang MJ, Yang M, Zhou YY, Zhang RJ, Cao GX, Cai GM, Wang GJ.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Jan;22(1):88-91. Chinese.

PMID:
16388754
9.

Anti-angiogenic potential of tocotrienol in vitro.

Miyazawa T, Inokuchi H, Hirokane H, Tsuzuki T, Nakagawa K, Igarashi M.

Biochemistry (Mosc). 2004 Jan;69(1):67-9.

10.

Antiangiogenic properties of silver nanoparticles.

Gurunathan S, Lee KJ, Kalishwaralal K, Sheikpranbabu S, Vaidyanathan R, Eom SH.

Biomaterials. 2009 Oct;30(31):6341-50. doi: 10.1016/j.biomaterials.2009.08.008.

PMID:
19698986
11.

Effects of cytoskeletal disrupting agents on replication of bovine endothelium.

Selden SC 3rd, Rabinovitch PS, Schwartz SM.

J Cell Physiol. 1981 Aug;108(2):195-211.

PMID:
7263771
12.

Farnesyltransferase inhibitors target multiple endothelial cell functions in angiogenesis.

Scott AN, Hetheridge C, Reynolds AR, Nayak V, Hodivala-Dilke K, Mellor H.

Angiogenesis. 2008;11(4):337-46. doi: 10.1007/s10456-008-9115-3.

PMID:
18758974
13.

[In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides].

Chen HM, Yan XJ, Wang F, Lin J, Xu WF.

Yao Xue Xue Bao. 2007 Jun;42(6):595-600. Chinese.

PMID:
17702394
14.

Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development.

Kruczynski A, Poli M, Dossi R, Chazottes E, Berrichon G, Ricome C, Giavazzi R, Hill BT, Taraboletti G.

Eur J Cancer. 2006 Nov;42(16):2821-32.

PMID:
16973349
15.

In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.

Chintalapati M, Truax R, Stout R, Portier R, Losso JN.

J Agric Food Chem. 2009 Jun 24;57(12):5201-10. doi: 10.1021/jf803818y.

PMID:
19476359
16.

Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases.

Kim SA, Lee HJ, Ahn KS, Lee HJ, Lee EO, Ahn KS, Choi SH, Jung SJ, Kim JY, Baek N, Kim SH.

Biol Pharm Bull. 2009 Jul;32(7):1142-7.

17.

Anti-angiogenic and anti-metastatic effects of beta-1,3-D-glucan purified from Hanabiratake, Sparassis crispa.

Yamamoto K, Kimura T, Sugitachi A, Matsuura N.

Biol Pharm Bull. 2009 Feb;32(2):259-63.

18.

Structure and anti-proliferation function of 5,5-diphenyl-2-thiohydantoin (DPTH) derivatives in vascular endothelial cells.

Cheng CK, Wu J, Liu Y, Lee TS, Kang SJ, Sheu MT, Lee WS.

Vascul Pharmacol. 2008 Feb-Mar;48(2-3):138-42. doi: 10.1016/j.vph.2008.01.007.

PMID:
18295547
19.

Modulation of adjuvant arthritis in the rat by 2-methoxyestradiol: an effect independent of an anti-angiogenic action.

Issekutz AC, Sapru K.

Int Immunopharmacol. 2008 May;8(5):708-16. doi: 10.1016/j.intimp.2008.01.016.

PMID:
18387513
20.

Discovery of potent and practical antiangiogenic agents inspired by cortistatin A.

Czakó B, Kürti L, Mammoto A, Ingber DE, Corey EJ.

J Am Chem Soc. 2009 Jul 1;131(25):9014-9. doi: 10.1021/ja902601e.

PMID:
19469509

Supplemental Content

Support Center